소세포 폐암 (SCLC) 의 치료 Small-cell lung cancer (SCLC) - 13–15% of newly diagnosed lung cancer per year. - Most patients present with extensive stage disease --> expected survival : 2~4 months without Tx. Five year survival rates - Limited-stage SCLC : 10–13% - Extensive-stage SCLC : 1–2% WHO classification - 2 types of SCLC : pure and combined - Up to 28% may present with combined SCLC histology SCLC..
